MNPR - Monopar Therapeutics Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts5553
Avg. Estimate-0.18-0.15-0.63-0.45
Low estimate-0.2-0.19-0.77-0.62
High estimate-0.16-0.11-0.45-0.34
Year ago EPS-0.22-0.19-0.83-0.63
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts4443
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.21-0.22-0.2-0.22
Actual EPS-0.22-0.19-0.23-0.19
Difference-0.010.03-0.030.03
Surprise %-4.80%13.60%-15.00%13.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.18-0.15-0.63-0.45
7 days ago-0.18-0.15-0.63-0.45
30 days ago-0.19-0.18-0.73-0.54
60 days ago-0.19-0.18-0.73-0.54
90 days ago-0.22-0.2-1.01-0.99
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1443
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMNPRIndustrySector(s)S&P 500
Current qtr.18.20%N/AN/AN/A
Next qtr.21.10%N/AN/AN/A
Current year24.10%N/AN/AN/A
Next year28.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A